HIV is a virus that continues to perplex experts due to its ever-changing features when present in the body. As a result, no permanent cure or rapid diagnosis procedure has yet been discovered. As a result, researchers all over the world are always looking for a new cure or medication for HIV patients. Can you envision a home test kit that gives you the results right away? The expected response is “no.” However, given the current state of medical diagnostic test advancement, the response can be revised to “Yes.”
A newly advanced INSTI HIV Self Test was recently discovered by bioLytical, a laboratory based in Canada. The lab has already begun selling its products in a number of pharmacies in Belgium. The new test takes only a few minutes to complete and provides an appropriate and accurate result. In comparison to other blood tests, the HIV Self Test simply only a single drop of blood to diagnose HIV infection. It is a more efficient, appropriate, and convenient solution than the older traditional procedures, which took days or weeks to complete, or the home kits, which took 15 to 20 minutes to complete. The HIV Self Test is an over-the-counter variant of the INSTI point-of-care test that is now utilised in European regions. In comparison to other currently utilised tests, the new test is expected to diagnose HIV two weeks earlier.
The introduction of the HIV Self Test in Belgium will make diagnostic testing more accessible to a wider range of people around the world. The new test is user-friendly, cost-effective, and simple, and it empowers people to make health decisions and take the appropriate steps in their own homes.
The in-vitro medical diagnostic test was developed by bioLytical using the INSTI technology platform. The company intends to commercialise the device in different markets throughout the world after receiving CE Mark and FDA approval. The INSTI HIV or Syphilis Multiplex test, on the other hand, is now only available in Europe.
BioLytical has launched a number of different tests, including Zika, Ebola, Chikungunya, Dengue, and Hepatitis C, in addition to point-of-care in-vitro medical diagnostics.